CClinicalTrials.gg
RecruitingNCT06352788AFOSVAUpdated Jan 15, 2026

From Opinion to Evidence: Multi-site Evaluation of Custom Dynamic Orthosis Best Practices

An interventional study of Modular Carbon Fiber Custom Dynamic Orthosis (CDO) and Mono Carbon Fiber Custom Dynamic Orthosis (CDO) in Foot Injury, sponsored by Jason Wilken. Recruiting at 5 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-01-15.

Sponsored by Jason Wilken · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jul 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

This study is designed to support evidence-based practice and optimal care by evaluating how different configurations of two types of carbon fiber custom dynamic orthoses (CDOs) influences outcomes following traumatic lower extremity injury.

Read the detailed description

This study is designed to evaluate how different configurations of two types of carbon fiber custom dynamic orthoses (CDOs) influence outcomes following traumatic lower extremity injury. In this study, adult participants who still experiencing deficits including weakness and/or immobility more than two years post traumatic lower extremity injury will be randomized and fit with either modular or monolithic CDO.

Participants will then be evaluated without a CDO and with the CDO in three configurations in a randomized order: a proposed optimal benchmark configuration, a variation with the device in more dorsiflexion, and a variation with the device in greater plantarflexion. Multiple well-established tests will be used to compare outcomes between the different configurations.

02

Conditions studied

  • Foot Injury

Browse trials for

Keywords

  • Ankle Foot Orthosis
  • Carbon Fiber
  • Gait
  • Biomechanics
  • Physical Performance
03

In context

Foot Injuries

51 studies on the registry are indexed under Foot Injuries; 10 are open to participants now.

This study's planned enrollment of 35 is below the median of 52 across 38 interventional studies indexed under Foot Injuries.

Browse Foot Injuries studies →

Lead sponsor

Jason Wilken is the lead sponsor of 3 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Between the ages of 18 and 65
  • 2 or more years from a traumatic injury below the knee
  • Ability to be fit with an orthosis
  • Any of the following:

    • Weakness of ankle plantarflexors (\<4/5 on manual muscle test)
    • Limited pain-free ankle motion (dorsiflexion (DF) \<10° or plantarflexion (PF) \<20°)
    • Mechanical pain with loading to hindfoot/midfoot (>=4/10 Numerical pain rating scale)
    • Fusion or candidate for fusion of the ankle or hindfoot
    • Candidate for amputation secondary to ankle/foot injury and impairment

Exclusion criteria

Exclusion Criteria:

  • Pain greater than 8/10 at rest
  • Ankle weakness or spasticity as a result of spinal cord injury or central nervous system pathology
  • Use of an orthosis including the knee
  • Non-ambulatory
  • Surgery on study limb anticipated in next 4 months
  • Medical or psychological conditions that would influence functional testing (e.g., severe traumatic brain injury, stroke, heart disease, vestibular disorder)
  • Neurologic, musculoskeletal, or other conditions limiting function of the contralateral extremity
  • Uncorrected visual or hearing impairments
  • Pregnancy
  • Non-English speaking
  • BMI > 40
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
35 participants (estimated)

Study arms

  • Experimental
    NoCDO, A, B, C

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration A, CDO configuration B, and finally CDO configuration C.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    NoCDO, A, C, B

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration A, CDO configuration C, and finally CDO configuration B.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    NoCDO, B, A, C

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration B, CDO configuration A, and finally CDO configuration C.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    NoCDO, B, C, A

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration B, CDO configuration C, and finally CDO configuration A.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    NoCDO, C, A, B

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration C, CDO configuration A, and finally CDO configuration B.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

  • Experimental
    NoCDO, C, B, A

    Participants will first be evaluated without a CDO (NoCDO), then in CDO configuration C, CDO configuration B, and finally CDO configuration A.

    Device: Modular Carbon Fiber Custom Dynamic Orthosis (CDO) · Device: Mono Carbon Fiber Custom Dynamic Orthosis (CDO)

Interventions

  • DeviceModular Carbon Fiber Custom Dynamic Orthosis (CDO)

    The CDO will use a modular design that includes a full length foot plate, a posterior carbon fiber strut, and a proximal cuff that wraps around the leg just below the knee.

    Also known as: Reaktiv (Fabtech Systems LLC, Everett WA)

  • DeviceMono Carbon Fiber Custom Dynamic Orthosis (CDO)

    The CDO will use a mono design that includes a full length foot plate, a posterior carbon fiber strut, and a proximal cuff that wraps around the leg just below the knee.

    Also known as: Posterior Spring (Bio-Mechanical Composites, Inc., Des Moines, IA)

06

What researchers measure

Primary outcomes

  1. PROMIS Physical Function

    The Patient Reported Outcome Information System (PROMIS) Physical Function Computer Adaptive Test (CAT) is a computerized assessment measuring physical function. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents greater physical function than the population average. Larger scores are better.

    Time frame: Baseline

  2. PROMIS Pain Interference

    The Patient Reported Outcome Information System (PROMIS) Pain Interference Computer Adaptive Test (CAT) is a computerized assessment measuring pain interference. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents greater pain interference than the population average. Lower scores are better.

    Time frame: Baseline

  3. OPUS Satisfaction with Device and Services

    Satisfaction with device and services will be assessed using the Orthotics Prosthetics Users' Survey Satisfaction With Device and Services Score (11-55). Lower scores indicate a better outcome and more satisfaction with the CDO and accompanying services.

    Time frame: Baseline

  4. Modified Socket Comfort Score - Comfort

    Participants were asked to rate the comfort of each CDO configuration on a scale from 0-10 with 0 = most uncomfortable to 10 = most comfortable. Higher scores indicate more comfortable conditions, and are considered better.

    Time frame: Baseline

  5. Modified Socket Comfort Score - Smoothness

    Participants were asked to rate the smoothness of each CDO configuration on a scale from 0-10 with 0 = most smooth to 10 = least smooth. Lower scores indicate smoother conditions, and are considered better.

    Time frame: Baseline

  6. Numerical Pain Rating Scale

    Pain will be assessed using a standard 11-point numerical pain rating scale (NPRS), in which 0 = no pain and 10 = worst pain imaginable. Lower scores are considered better.

    Time frame: Baseline

  7. Preference - Ranked

    The participant will be asked to rank order the conditions they have completed testing for at each visit: at the 3rd visit they will rank order their preference for using no orthosis or using the CDO in the first configuration, at the 4th visit they will rank order their preference for using no orthosis, using the CDO in the first configuration, and using the CDO in the second configuration, at the 5th visit they will rank order their preference for using no orthosis, using the CDO in the first configuration, using the CDO in the second configuration, and using the CDO in the third configuration.

    Time frame: Baseline

  8. Preference - CDO Configuration

    For each CDO configuration, participants will be asked to rank their preference on a scale from 0 (least preferred) to 10 (most preferred) for a number of questions concerning CDO use. Higher scores indicate higher preferences and are considered better.

    Time frame: Baseline

  9. Four Square Step Test (seconds)

    The 4SST (seconds) is a standardized timed test of balance and agility. Participants start in the lower left quadrant of a Maltese cross setting on the floor and are timed as they move counterclockwise (forward, right, backward, left) and then clockwise (right, forward, left, backward) around the cross. Participants are instructed to move as quickly as they safely can. Lower times indicate faster completion of the test and are considered better results.

    Time frame: Baseline

  10. Sit to Stand 5 Times (seconds)

    STS5 (seconds) is a well-established timed measure of lower limb muscle strength and power. Participants are instructed to stand up and sit down 5 times as fast as possible. Lower scores indicate a faster time to complete the test and are considered better results.

    Time frame: Baseline

  11. Center of Pressure Velocity Magnitude (m/s)

    The center of pressure (CoP) is the centroid of the forces acting on the foot during gait. The magnitude of the peak center of pressure velocity (m/s) is the fastest the CoP moves during gait.

    Time frame: Baseline

  12. Center of Pressure Velocity Timing (%stance)

    The center of pressure (CoP) is the centroid of the forces acting on the foot during gait. The timing of the peak center of pressure velocity, is the percent of the stance phase (%stance) where the CoP is moving fastest during gait.

    Time frame: Baseline

  13. Ankle Zero Moment Crossing (%stance)

    The ankle zero moment crossing is the point during the stance phase of gait (%stance) where the ankle moment transitions from a dorsiflexion to a plantarflexion moment.

    Time frame: Baseline

  14. Peak Ankle Dorsiflexion (degree)

    Participants completed a biomechanical gait analysis session. Sagittal plane peak ankle joint dorsiflexion angle (degree) that occurs late in the stance phase of gait.

    Time frame: Baseline

  15. Peak Ankle Plantarflexion Moment (Nm/kg)

    Participants completed a biomechanical gait analysis session. Sagittal plane peak ankle joint plantarflexion moment normalized to participant body weight (Nm/kg) that occurs late in the stance phase of gait.

    Time frame: Baseline

  16. Peak Ankle Push-Off Power (W/kg)

    Participants completed a biomechanical gait analysis session. Sagittal plane peak ankle joint power normalized to body weight (W/kg) occurs late in the stance phase of gait.

    Time frame: Baseline

Secondary outcomes

  1. PROMIS Satisfaction with Participation in Social Activities

    The Patient Reported Outcome Information System (PROMIS) satisfaction with participation in social activities Computer Adaptive Test (CAT) is a computerized assessment measuring satisfaction with participation in social activities. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents greater participation in social activities than the population average, larger scores are considered better.

    Time frame: Baseline

  2. PROMIS Satisfaction with Participation in Discretionary Social Activities

    The Patient Reported Outcome Information System (PROMIS) satisfaction with participation in social activities Computer Adaptive Test (CAT) is a computerized assessment measuring satisfaction with participation in social activities. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents greater participation in discretionary social activities than the population average, larger scores are considered better.

    Time frame: Baseline

  3. PROMIS Depression

    The Patient Reported Outcome Information System (PROMIS) depression Computer Adaptive Test (CAT) is a computerized assessment measuring depression. It is scored using a T-score in which 50 is the mean of a relevant reference population and 10 is the standard deviation (SD) of that population. In a given PROMIS domain, a T-score above 50 represents greater levels of depression than the population average, lower scores are considered better.

    Time frame: Baseline

Other outcomes

  1. Ankle Range of Motion (degrees)

    Participants completed a biomechanical gait analysis session. Sagittal plane ankle range of motion (degrees) was measured throughout the gait cycle. Smaller range of motion is expected with each CDO.

    Time frame: Baseline

07

Study locations

5 of 5 sites recruiting
  • Naval Medical Center San Diego - Clinical Biomechanics Laboratory
    San Diego, California 92134, United States
    Recruiting
  • University of Iowa
    Iowa City, Iowa 52242, United States
    Recruiting
  • Minneapolis VA Health Care System - Motion Analysis Laboratory
    Minneapolis, Minnesota 55417, United States
    Recruiting
  • Mayo Clinic - Motion Analysis Lab
    Rochester, Minnesota 55905, United States
    Recruiting
  • Vanderbilt University - Zelik Lab For Biomechanics & Assistive Technology
    Nashville, Tennessee 37212, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06352788
Lead sponsor
Jason Wilken
Collaborators
Mayo Clinic, Vanderbilt University Medical Center, Navy Medical Center San Diego, Minneapolis Veterans Affairs Medical Center, Johns Hopkins University
Responsible party
Jason Wilken (Associate Professor, University of Iowa) — Sponsor-investigator
First posted
Apr 8, 2024
Start date
Jul 2, 2024
Primary completion
Aug 31, 2027 (estimated)
Completion
Sep 1, 2028 (estimated)
Last update
Jan 15, 2026

Study contacts

Jason M Wilken, PT, PhD
Contact
jason-wilken@uiowa.edu
319-335-6857
Molly S Pacha, MS, ATC, LAT
Contact
molly-pacha@uiowa.edu
319-290-7596
Jason M Wilken, PT, PhD
principal investigator · University of Iowa

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion